Difference between revisions of "Team:CU-Boulder/Results"
| Line 57: | Line 57: | ||
<h3> Two-Plasmid System localizes fluorescent proteins </h3> | <h3> Two-Plasmid System localizes fluorescent proteins </h3> | ||
| + | <figure align="center"> | ||
| + | <img src="https://static.igem.org/mediawiki/2016/9/94/TCU-results12.PNG" style="width:800px;height:285px; padding: 10px 10px 10px 10px;"> | ||
| + | <figcaption align="center">Two-Plasmid System localizes fluorescent proteins</figcaption> | ||
| + | |||
| + | |||
<p class = "main"> | <p class = "main"> | ||
We used standard BioBrick plasmids pSB4A5 and and introduced high (BBa_314100), low (BBa_314100), and lactose (BBa_K314103) promoters with the EutS compartmental structure protein (BBa_2129001), along with a EutC1-19 tagged enhanced GFP fluorescent protein (BBa_2129003) on pSB1K3 with the same high and low promoters as well as an arabinose inducible promoter (BBa_2129006, 007). Comparative localization was demonstrated by comparison to fluorescent microscopy of non-EutS expressing cells. </p> | We used standard BioBrick plasmids pSB4A5 and and introduced high (BBa_314100), low (BBa_314100), and lactose (BBa_K314103) promoters with the EutS compartmental structure protein (BBa_2129001), along with a EutC1-19 tagged enhanced GFP fluorescent protein (BBa_2129003) on pSB1K3 with the same high and low promoters as well as an arabinose inducible promoter (BBa_2129006, 007). Comparative localization was demonstrated by comparison to fluorescent microscopy of non-EutS expressing cells. </p> | ||
Revision as of 01:36, 17 October 2016
Results
We set out at the beginning of the summer with the aim of consistently producing a bacterial microcompartment from a single protein, with the objective of adding a non-canonical amino acid at a point within its sequence that enables us to break these self-forming compartments apart using light. We have produced the following results:
1. We have successfully produced a one-protein BioBrick compatible part that forms microcompartments (EutS, BBa_K2129001)
2. We have tested and demonstrated the results of different expression levels of our EutS compartment with variable levels of tagged eGFP using a variable two-plasmid system and a variety of promoters (BBa_K2129003-K2129007)
3. We successfully mutated amber stop codons at at least three loci in the EutS
4. We introduced a 3-plasmid system using the AzoPhe pEVOL plasmid from the Shultz lab ( shultzlablink) and then visualized the results of adding irradiated phenylalanine-4’-azobenzene to the medium of cells with the mutated plasmids
5. We attempted to produce similar results using genome modification of NEB-5alpha e.coli cells, and produced a library of genomic edits towards this end.
Construction of the EutS BioBrick compatible part
Using the part EutSMNLK (BBa_K311004), we PCR amplified out the S protein of the operon and cloned it alone onto a plasmid backbone. Testing using our two-plasmid system has demonstrated that EutS does indeed produce localization of EutC tagged fluorescent proteins, as described in Schmidt-Dannert et al. 2016 (PMID: 27063436). Our system is fully BioBrick compatible and extremely simple, producing localization and compartmentalization with a minimum of necessary protein expression.
Two-Plasmid System localizes fluorescent proteins
We used standard BioBrick plasmids pSB4A5 and and introduced high (BBa_314100), low (BBa_314100), and lactose (BBa_K314103) promoters with the EutS compartmental structure protein (BBa_2129001), along with a EutC1-19 tagged enhanced GFP fluorescent protein (BBa_2129003) on pSB1K3 with the same high and low promoters as well as an arabinose inducible promoter (BBa_2129006, 007). Comparative localization was demonstrated by comparison to fluorescent microscopy of non-EutS expressing cells.
Fluorescent microscopy demonstrates increased localization of fluorescent proteins when the EutS plasmid is present. We have demonstrated and characterized this using three different EutS promoter systems and found that of the three, EutS Mid and Low (BBa_2129004,005) produce the best results. Some characterization was attempted using an IPTG-inducible cassette, however due to the medium no particular difference in expression was observed in non-IPTG media.
Localization of the EutC1-19 - eGFP system was tested with low, high, and arabinose cassettes on pSB1K3. Localization was always noticeable with good levels of EutS expression, however, cells would frequently overexpress eGFP resulting in sporadic cells being extremely fluorescent and making visualization of surrounding cells more difficult. The best results can be seen with EutS with a low cassette (BBa_2129006) and araC-Pbad (BBa_K808000)under non-arabinose added medium using Luria-Bertani broth (this is documented behavior on the parts page for BBa_K808000).
These results demonstrate that the standard BioBrick promoters and plasmids are able to produce similar results to those previously discovered, with some possibility of reduced fidelity and frequency of ‘misbehavior’ by individual cells.
Mutation of EutS Sequence to introduce Amber stop codons
Using site directed mutagenesis, we changed the sequence of our EutS Low plasmid construct to instead use a Mid promoter, and we introduced amber stop codons into the sequence of EutS at residues that we selected based on predictive protein modelling with Rosetta and Pymol. Sequencing confirmed that several of these plasmids were successfully mutated at the loci we selected, including the part EutS G26-Amber (BBa_2129002) which we characterized more fully with our three plasmid system and fluorescent microscopy.
Figure: Mutagenesis protocol figure
Introduction of azobenzene amino acids to EutS structure
Using QuikChange PCR mutagenesis, we introduced Amber (UAG) stop codons to the EutS sequence at residues predictively modelled to produce super and substructure altering effects. Once sequenced and confirmed for incorporation of amber codons at desired sites, we performed a co-transformation of eGFP Low (BBa_2129006) and the pEVOL AzoPhe plasmid provided by the Shultz lab, and then introduced our mutated EutS Mid plasmids via electroporation.
Fluorescent microscopy of the tri-plasmid system without mutation produced similar results to the two plasmid system with successful growth in tri-antibiotic media, confirming the viability of the three-plasmid protocol. Amber codon mutation into the sequence of the EutS gene was sequence confirmed at five loci, all of which were transformed with the prepared two-plasmid e.coli and viewed under fluorescent microscopy. With reduced efficiency from the control, eGFP localization was still notable in the mutant-plasmid transformed cells, suggesting successful incorporation of phenylalanine-4’-azobenzene (AzoPhe) into the EutS structure. Under repeated exposure to blue-wavelength light, localization showed significant diminishment, raising the possibility of successful cage disruption under trans-AzoPhe conditions.
Genome modification of NEB 5(alpha) cells for IPTG-inducible Eut expression
Genome sequencing of the NEB-5alpha cells used for all our cloning was performed to confirm the presence of a functional e.coli Eut operon. Upon confirmation of gene presence and function, we performed high-throughput mutation to attempt to reproduce our two-plasmid expression system with genomic transcription, introducing an IPTG-inducible promoter in lieu of the normal ethanolamine operon induction into the genome.
Due to the considerable time-latency this procedure requires, we did not successfully produce functional mutants at the time of the competition, but we did produce a mutation library and transformed our cells.
Figure: Procedure overview
In the future
We plan to continue testing our designed mutations to find the optimal compartment for applications. They will then be compared to the genome scale edits.
Considerations for Replication of the Experiment
Hopefully we plan to keep our experimentation as consistent as possible as to best compare the results. If we find there are multiple optimal Eut complexes, the next step would be to find the ones that are the most stable when isolated, and how much light activation is needed to disperse the compartments. Possible future applications could include isolating an enzymatic pathway inside the Eut complex to maximize its efficiency.
